Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia

Antonio Ruggiero*, Gabriella De Rosa, Daniela Rizzo, A Leo, Palma Maurizi, Alessia De Nisco, Francesca Vendittelli, Cecilia Zuppi, Alvaro Mordente, Riccardo Riccardi

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo

35 Citazioni (Scopus)

Abstract

Despite significant improvements in the prognosis of childhood acute lymphoblastic leukaemia (ALL), the risk of anthracycline-induced cardiovascular disease remains a major concern. This study was designed to investigate the role of the myocardial performance index (MPI) and serum concentrations of biomarkers (cTnT and NT-pro-BNP) in the early detection of subclinical anthracycline-induced functional alterations in children with ALL.
Lingua originaleInglese
pagine (da-a)927-933
Numero di pagine7
RivistaInternational Journal of Clinical Oncology
Volume18
Numero di pubblicazione5
DOI
Stato di pubblicazionePubblicato - 2013

All Science Journal Classification (ASJC) codes

  • Chirurgia
  • Ematologia
  • Oncologia

Keywords

  • Myocardial performance index
  • biochemical markers
  • cardiotoxicity
  • doxorubicin

Fingerprint

Entra nei temi di ricerca di 'Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia'. Insieme formano una fingerprint unica.

Cita questo